Contact us for a free case consultation 866-281-8659

Living Safer Magazine

Check out the latest issue of D’Amore Law Group’s Living Safer magazine!

Categories

Archive for the ‘Tysabri’ Category

FDA Confirms 13 Cases of Progressive Multifocal Leukoencephalopathy in Patients Receiving Natalizumab (Tysabri) for Multiple Sclerosis
Tuesday, November 3rd, 2009

FDA reports 13 confirmed cases of progressive multifocal leukoencephalopathy from patients taking Tysabri